Log in to save to my catalogue

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4966331

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

About this item

Full title

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.3036-3052

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

In preclinical models of glioblastoma, antigen escape variants can lead to tumor recurrence after treatment with CAR T cells that are redirected to single tumor antigens. Given the heterogeneous expression of antigens on glioblastomas, we hypothesized that a bispecific CAR molecule would mitigate antigen escape and improve the antitumor activity of...

Alternative Titles

Full title

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4966331

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4966331

Other Identifiers

ISSN

0021-9738,1558-8238

E-ISSN

1558-8238

DOI

10.1172/JCI83416

How to access this item